Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

Novo’s diabetes pill defeats Merck’s Januvia in trial

Novo’s diabetes pill defeats Merck’s Januvia in trial

Comparing oral semaglutide to Merck &Co’s DPP-4 inhibitor Januvia (sitagliptin), PIONEER 7 investigated the efficacy and safety of the GLP-1 inhibitor in people with type 2 diabetes. ... PIONEER 4 saw the enrolment of 711 people with type 2 diabetes

Latest news

More from news
Approximately 7 fully matching, plus 138 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to the progress in modern medicine.

  • The rise of real-world evidence The rise of real-world evidence

    Diabeter, a Dutch chain of type 1 diabetes clinics bought by Medtronic in 2015, is an example of this trend. ... and then have it come through a pipe so it populates our practice management system, ”Sue Willman, vice president of global diabetes

  • Taking a lean and careful approach Taking a lean and careful approach

    ulcerative colitis, type 1 diabetes and inflammatory bowel disease. ... This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels.

  • Strategic planning in the digital age Strategic planning in the digital age

    In the type 1 diabetes therapy area, healthcare professionals in the UK alone published more than 50, 000 posts on public social media discussing the disease during 2016. ... A study by CREATION of healthcare professional needs in type 1 diabetes,

  • Deal Watch December 2016 Deal Watch December 2016

    Licensor / Acquisition target. Licensee / Acquirer. Deal type. Product /technology. ... Defymed. Not disclosed. Not disclosed. Bio-artificial pancreas for Type 1 diabetes.

More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest appointments

  • JDRF names new CEO JDRF names new CEO

    The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to develop treatment options for type 1 diabetes.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to

  • JDRF Appeal Video

    JDRF Appeal Video. JDRF video for the Wellington Appeal. JDRF is the type 1 diabetes charity, improving lives until they find the cure. ... They're totally focused on type 1 diabetes, and are run by people with type 1, for people with type 1.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics